Evidence map›Paper›PMID 28803095›Full record

ArticlePsychiatry research2017

Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study.

Nehal P Vadhan, Cheryl M Corcoran, Gill Bedi, John G Keilp, Margaret Haney

Abstract read
In one paragraph

Article in Psychiatry research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Quantifying cannabis: A field study of marijuana quantity estimation.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nehal P VadhanDepartments of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine and the Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, 1010 Northern Blvd, Suite #311, Great Neck, NY 11021, USA. Electronic address: nvadhan@northwell.edu.
Cheryl M CorcoranDepartment of Psychiatry, Columbia University Medical Center and the New York State Psychiatric Institute, New York, NY, USA.
Gill BediDepartment of Psychiatry, Columbia University Medical Center and the New York State Psychiatric Institute, New York, NY, USA.
John G KeilpDepartment of Psychiatry, Columbia University Medical Center and the New York State Psychiatric Institute, New York, NY, USA.
Margaret HaneyDepartment of Psychiatry, Columbia University Medical Center and the New York State Psychiatric Institute, New York, NY, USA.
New York State Psychiatric InstituteFeinstein Institute for Medical Research · US

Funding

PHARMACOLOGICAL TREATMENT OF MARIJUANA DEPENDENCEP50DA009236 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI KLEBER, HERBERT DAVID · 1994 to 2013
$39.4M
Thought disorder and social cognition in clinical risk states for schizophreniaR01MH107558 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI CORCORAN, CHERYL MARY · 2016 to 2020
$3.3M
Longitudinal Imaging of Patients at Clinical Risk for Psychosis.R01MH093398 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SMALL, SCOTT A · 2011 to 2015
$2.5M
Medication Development for Marijuana RelapseR01DA019239 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HANEY, MARGARET · 2004 to 2008
$2.5M
Neurobehavioral Mechanisms of Decisions to Smoke Marijuana and Cocaine in HumansK23DA034877 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BEDI, GILLINDER I. · 2013 to 2017
$930k
Olfaction in the Psychosis Prodrome: Behavioral and ERP MeasuresR21MH086125 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BRUDER, GERARD E, CORCORAN, CHERYL MARY · 2009 to 2010
$440k
NIDA NIH HHS K23 DA034877NIDA NIH HHS P50 DA009236NIDA NIH HHS R01 DA019239NIMH NIH HHS R01 MH093398NIMH NIH HHS R01 MH107558NIMH NIH HHS R21 MH086125
6 · The paper itself

Abstract

Marijuana use is associated with psychosis, but its effects are understudied in individuals with preexisting risk for psychotic disorders. This preliminary study examined the acute psychological and physiological effects of smoked marijuana (0.0% or 5.5% Δ

Indexed as

Disease SusceptibilityProdromal SymptomsAdultCognitive DysfunctionFemaleHumansMaleMarijuana SmokingPsychoses, Substance-InducedRiskCannabisProdromal psychosisUltra high-risk

Identifiers

PMID28803095
PMCPMC5890804
OpenAlexW2741248765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.